InformasjonHøydesyke kan oppstå allerede ved 2000 meter over havet.
Akutt høydesyke
Høydesyke er symptomer som oppstår på grunn av manglende tilpasning til det lave oksygentrykket i store høyder.
Sist oppdatert:
18. juli 2023
Vil du vite mer
Dette dokumentet er basert på det profesjonelle dokumentet Høydesyke . Referanselisten for dette dokumentet vises nedenfor
Referanser
- Luks AM, Auerbach PS, Freer L, et al. Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Acute Altitude Illness: 2019 Update. Wilderness Environ Med. 2019;30(4S):S3‐S18. doi:10.1016/j.wem.2019.04.006 DOI
- Rostrup M. Høydemedisin-akutt høydesyke. Norsk legemiddelhåndbok. Sist revidert 11.01.2023. www.legemiddelhandboka.no
- Maggiorini M, Buhler B, Walter M, et al. Prevalence of acute mountain sickness in the Swiss Alps. BMJ 1990;301:853-855. British Medical Journal
- Gallagher SA, Hackett P. Acute mountain sickness and high altitude cerebral edema. UpToDate, last updated Jun 16, 2022. UpToDate
- Luks AM, Swenson ER, Bärtsch P. Acute high-altitude sickness. Eur Respir Rev. 2017;26(143):160096. Published 2017 Jan 31. PMID: 28143879 PubMed
- Imray C, Booth A, Wright A, Bradwell A. Acute altitude illnesses. Clinical review. BMJ 2011; 343: d4943. BMJ (DOI)
- Firth PG, Zheng H, Windsor JS, et al. Mortality on Mount Everest, 1921-2006: descriptive study. BMJ 2008; 337: a2654. BMJ (DOI)
- Bird BA, Wright AD, Wilson MH, et al. High altitude ataxia--its assessment and relevance. Wilderness Environ Med 2011; 22: 172-6. pmid:21664562 PubMed
- Gallagher SA, Hackett P, Rosen JM. High-altitude illness: Physiology, risk factors, and general prevention. UpToDate, last updated Sep 23, 2022. UpToDate
- Gao D, Wang Y, Zhang R, Zhang Y. Efficacy of Acetazolamide for the Prophylaxis of Acute Mountain Sickness: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials. Am J Med Sci. 2021;361(5):635-645. PubMed
- McIntosh SE, Hemphill M, McDevitt MC, et al. Reduced Acetazolamide Dosing in Countering Altitude Illness: A Comparison of 62.5 vs 125 mg (the RADICAL Trial). Wilderness Environ Med. 2019;30(1):12‐21. doi:10.1016/j.wem.2018.09.002 DOI
- Furian M, Mademilov M, Buergin A, et al. Acetazolamide to Prevent Adverse Altitude Effects in COPD and Healthy Adults. NEJM Evid 2021. doi:10.1056/EVIDoa2100006 DOI
- Burns P, Lipman GS, Warner K, et al. Altitude Sickness Prevention with Ibuprofen Relative to Acetazolamide. Am J Med. 2019;132(2):247‐251. doi:10.1016/j.amjmed.2018.10.021 DOI
- Jones BE, Stokes S, McKenzie S, Nilles E, Stoddard GJ. Management of high altitude pulmonary edema in the Himalaya: a review of 56 cases presenting at Pheriche medical aid post (4240 m). Wilderness Environ Med. 2013;24(1):32‐36. doi:10.1016/j.wem.2012.07.004 DOI
- Gallagher SA, Hackett P. High-altitude pulmonary edema. UpToDate, last updated Oct 04, 2022. UpToDate
- Gertsch JH, Lipman GS, Holck PS, et al. Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: The Headache Evaluation at Altitude Trial (HEAT). Wilderness Environ Med 2010; 21: 236-43. PubMed
- Nieto Estrada VH, Molano Franco D, Medina RD, Gonzalez Garay AG, Martí-Carvajal AJ, Arevalo-Rodriguez I. Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs. Cochrane Database Syst Rev. 2017 Jun 27. 6:CD009761. Cochrane (DOI)